Background: Cardiomyopathies are a heterogeneous group of pathologies characterized by
structural and functional alterations of the heart. Aims: The purpose of this narrative review is …

Cardiac amyloidosis (CA), once thought to be a rare disease, is increasingly recognized due
to enhanced clinical awareness and better diagnostic imaging. CA is becoming of …

Background: Mitral valve prolapse (MVP) is a frequent disease that can be complicated by
mitral regurgitation (MR), heart failure, arterial embolism, rhythm disorders, and death. Left …

Heart failure (HF) is highlighted by its burdening symptom-limited exercise capacity and
recurrent hospitalizations. Despite substantial advances regarding disease-modifying drugs …

The population of patients with cancer is rapidly expanding, and the diagnosis and
monitoring of cardiovascular complications greatly rely on imaging. Numerous advances in …

Background Photon-counting detector (PCD) CT provides comprehensive spectral data with
every acquisition, but studies evaluating myocardial extracellular volume (ECV) …

Cardiac magnetic resonance (CMR) has become an essential tool for the evaluation of
patients affected or at risk of developing cardiomyopathies (CMPs). In fact, CMR not only …

Importance Magnetic resonance imaging (MRI) is the modality of choice for many conditions.
Conditional devices and novel protocols for imaging patients with legacy cardiac …

Cardiac fibrosis is associated with non-ischemic dilated cardiomyopathy, increasing its
morbidity and mortality. Cardiac fibroblast is the keystone of fibrogenesis, being activated by …

Immunoglobulin light chain amyloidosis (AL) should be considered in any patient that
presents to a cancer care provider with nephrotic range proteinuria, heart failure with …